Know Cancer

or
forgot password


N/A
18 Years
N/A
Not Enrolling
Both
Colon Cancer

Thank you

Trial Information


Inclusion Criteria:



1. 18 years of age

2. Primary, non-metastatic [Stage I, II (localized, node negative), or III (localized,
node positive)] colon carcinoma confirmed by tissue biopsy or colon mass clinically
consistent with cancer and eventually confirmed by pathology

3. Palpable mass at time of surgery

4. Capable of providing informed consent

Exclusion Criteria:

1. Prior radiation or chemotherapy

2. Non-palpable colon tumor

3. Recurrent or Stage IV (metastatic) colon cancer

4. Unable to give informed consent

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Define the rate of upstaging of colon carcinoma lymph node metastasis with define the rate of upstaging of colon carcinoma lymph node metastasis with sentinel lymph node (SLN) mapping

Outcome Time Frame:

1 day

Safety Issue:

No

Principal Investigator

Alexander Stojadinovic

Investigator Role:

Principal Investigator

Investigator Affiliation:

Walter Reed Army Medical Center

Authority:

United States: Federal Government

Study ID:

03-20010

NCT ID:

NCT01623258

Start Date:

December 2002

Completion Date:

August 2011

Related Keywords:

  • Colon Cancer
  • Colonic Neoplasms

Name

Location
Walter Reed Army Medical Center Washington, District of Columbia  20307-5000